Advertisement
U.S. markets open in 3 hours 32 minutes

Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
17.95+0.15 (+0.84%)
At close: 03:04PM CST

Nanjing Hicin Pharmaceutical Co., Ltd.

No.1 Hengfa Road
Economic and Technological Development Zone
Nanjing 210046
China
86 25 8322 2911
https://www.hicin.cn/page1/index1

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees549

Key Executives

NameTitlePayExercisedYear Born
Mr. Yuping CaoGM & Chairman of the BoardN/AN/A1964
Mr. Li Qun WangSecretary & Deputy GMN/AN/A1988
Mr. Weicheng LiuDeputy General ManagerN/AN/A1981
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals, pharmaceutical preparations, and synthetic chemicals in China. It offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. The company also provides technical transferring services. In addition, it offers supply chain management services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is headquartered in Nanjing, China.

Corporate Governance

Nanjing Hicin Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.